Nyxoah SA (NYXH)
NASDAQ: NYXH · Real-Time Price · USD
1.345
+0.015 (1.13%)
Oct 2, 2026, 3:09 PM EDT - Market open
Nyxoah Market Cap
Nyxoah has a market cap or net worth of $133.63 million as of October 2, 2026. Its market cap has decreased by -27.76% in one year.
Market Cap
133.63M
Enterprise Value
91.07M
1-Year Change
-27.76%
Ranking
Category
Stock Price
$1.35
ChartMarket Cap Chart
Since the IPO on July 2, 2021, Nyxoah's market cap has decreased from $746.03M to $133.63M, a decrease of -82.09%. That is a compound annual growth rate of -27.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 135.16M | -34.51% |
| Dec 31, 2025 | 206.37M | -35.52% |
| Dec 31, 2024 | 320.06M | 137.05% |
| Dec 29, 2023 | 135.02M | -4.90% |
| Dec 30, 2022 | 141.98M | -73.96% |
| Dec 31, 2021 | 545.17M | -26.92% |
| Jul 2, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Profound Medical | 214.07M |
| RxSight | 197.57M |
| Neuronetics | 169.16M |
| Quanterix | 161.27M |
| Inogen | 158.70M |
| Owlet | 146.99M |
| Lucid Diagnostics | 121.21M |
| MaxCyte | 112.49M |